Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07429162 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Bacteriophage for Chronic Multidrug-Resistant Mycobacterium Abscessus Subsp. Abscessus Pulmonary Infection

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The objective of this study is to evaluate mycobacteriophage therapy using in-vitro validated mycobacteriophage DP-QB-MYA-002 in combination with conventional antimycobacterial agents for the treatment of multidrug-resistant Mycobacterium abscessus pulmonary disease, with the goal of reducing mycobacterial burden and improving pulmonary outcomes.
Trial Details
NCT Number NCT07429162
Lead Sponsor Alberta Health services
Conditions
(from sponsor)		 Mycobacterium Abscessus Infection, Bacteriophage Therapy, Pulmonary Disease
Related terms Lung Diseases, Mycobacterium Infections, Nontuberculous
Enrollment 1 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov